Clinical criterion:
Liver fibrosis stage of ≥ 2.
Conditions:
Treatment should be initiated by physicians with experience in the management of CHC patients.
Drug plan costs for OBV/PTV/RTV and DSV should not exceed the drug plan costs of other interferon-free regimens for the treatment of CHC.